LL-37
Human cathelicidin antimicrobial peptide studied for immune defense and wound healing research. 5mg lyophilized powder.
Description
Research Overview
LL-37 is the only human cathelicidin antimicrobial peptide, derived from the C-terminal domain of the 18 kDa human cationic antimicrobial protein (hCAP18). Research has investigated its broad-spectrum antimicrobial activity, immunomodulatory signaling, and roles in wound healing and angiogenesis in preclinical models.
Specifications
- Quantity: 5mg per vial
- Form: Lyophilized powder
- Purity: ≥99% (HPLC verified)
- Storage: -20°C, protect from light
For laboratory and research use only. Not for human consumption. This product is not a drug, food, or cosmetic and should not be used as a substitute for medical advice or treatment.
All products are sold strictly for in-vitro research and laboratory use only. Not for human consumption. By purchasing, you agree to our research policy and confirm you are a qualified researcher.
